Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Genocea to Present at Cantor Fitzgerald Healthcare Conference
-
Xencor to Present at Upcoming Investor Conferences
-
Aldeyra Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference
-
Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference
-
Calithera Biosciences to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference and the Leerink Partners Immuno-Oncology Roundtable
-
Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
-
Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference
-
Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference
-
BioTime to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Stemline Therapeutics to Present at Upcoming Investor Conferences
-
Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
OraSure Technologies to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
After-Hours Stock Movers 09/19: (KOOL) (GEMP) (CBAY) Higher; (BBBY) (IOVA) (ADBE) Lower (more...)
-
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
-
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts CymaBay Therapeutic (CBAY) at Overweight
-
Revance to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference
-
Exelixis to Present at the Cantor Fitzgerald Healthcare Conference on September 25
-
Theravance Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference
-
Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Nicox to present at the Cantor Fitzgerald 2017 Global Healthcare Conference
-
Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference
-
Matinas BioPharma to Present at the Cantor Fitzgerald Global Healthcare Conference
-
MEI Pharma to Present at Cantor Fitzgerald Global Healthcare Conference
-
Aldeyra Therapeutics (ALDX) Prices 3.45M Common Stock Offering at $7.25/Share
-
Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
-
Albireo to Present at Investor Conferences in September
-
Impax to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Abaxis, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Insmed to Present at Two September Investor Conferences
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Geron to Present at the Cantor Fitzgerald Healthcare Conference
-
Rigel to Present at Cantor Fitzgerald Global Healthcare Conference
-
Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017
-
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference
-
miRagen Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
XOMA to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Akari Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
ArQule to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26, 2017
-
Agenus to Present at Two Healthcare Investor Conferences In September
-
PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference
-
Mcewen Mining (MUX) Announces Bought Deal of $40.5M
-
McEwen Mining Announces Bought Deal of $40.5 Million
-
Puma Biotechnology to Present at Cantor Fitzgerald Healthcare Conference
-
Aquinox to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
-
Heron Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cidara Therapeutics to Present at Two Upcoming Conferences

